In an initial trial, patients who suffer from chronic nerve pain got relief from an interactive game that trained them to ...

The founder and former CEO of New Hampshire’s largest network of addiction treatment centers has been charged with ...

A drug that once showed promise as a treatment for alcohol use disorder did not work as expected, a new UCLA clinical trial ...

A $1.3 million clinic that will include pharmacy, mental health and traditional medical services is planned for Lancaster ...

The U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for ziftomenib, an investigational ...

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus ...

Substance use disorder can involve addiction to and dependency on alcohol, drugs, and more. Learn its causes, its treatments, ...

Three new JAK inhibitor medications have hit the market in recent years to treat alopecia. While they don't cure it, they are ...

Study results unveiled at ASCO show combining Enhertu with Perjeta can significantly delay tumor growth versus a regimen that ...

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent ...

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...